[Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF].

[1]  A. Özer,et al.  Sociodemographic Variables and Depression in Turkish Women From Polygamous Versus Monogamous Families , 2013, Health care for women international.

[2]  D. Furst,et al.  Therapeutic approach to familial Mediterranean fever: a review update. , 2011, Clinical and experimental rheumatology.

[3]  E. Shevach,et al.  Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy , 2008, Clinical & developmental immunology.

[4]  M. Lidar,et al.  Familial Mediterranean fever: clinical, molecular and management advancements. , 2007, The Netherlands journal of medicine.

[5]  E. Erken,et al.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever , 2006, Rheumatology International.

[6]  S. U. Kaymak,et al.  Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation? , 2005, Rheumatology International.

[7]  R. Gershoni-baruch,et al.  Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. , 2004, Seminars in arthritis and rheumatism.

[8]  S. Gangemi,et al.  Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. , 2002, Mediators of inflammation.

[9]  D. Zemer,et al.  Criteria for the diagnosis of familial Mediterranean fever. , 1997, Arthritis and rheumatism.

[10]  S. U. Kaymak,et al.  Selective serotonin reuptake inhibitors reduce the attack frequency in familial mediterranean Fever. , 2007, The Tohoku journal of experimental medicine.

[11]  M. Maes,et al.  Serotonin-Immune Interactions in Major Depression , 2000 .